AB Science is a pharmaceutical company specializing in the discovery, development, and commercialization of novel targeted therapies named protein kinase inhibitors. Their therapies treat diseases such as cancers, inflammatory diseases, and central nervous system diseases in both human and veterinary medicine. It serves hospitals and specialist physicians. The company was founded in 2001 and is headquartered in Paris, France.